{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T05:22:24Z","timestamp":1761196944775,"version":"3.37.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1002\/jps.21698","type":"journal-article","created":{"date-parts":[[2009,5,6]],"date-time":"2009-05-06T17:46:58Z","timestamp":1241632018000},"page":"4306-4315","source":"Crossref","is-referenced-by-count":6,"title":["Effect of Pregnancy on Nitrofurantoin Disposition in Mice"],"prefix":"10.1016","volume":"98","author":[{"given":"Yi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jashvant D.","family":"Unadkat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingcheng","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1002\/jps.21698_bb0010","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.ajog.2004.04.025","article-title":"Prescription drug use in pregnancy","volume":"191","author":"Andrade","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1002\/jps.21698_bb0015","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1517\/17425255.3.4.557","article-title":"Alterations in drug disposition during pregnancy","volume":"3","author":"Hodge","year":"2007","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1002\/jps.21698_bb0020","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/clpt.1980.158","article-title":"Serum protein binding of drugs during and after pregnancy in humans","volume":"28","author":"Dean","year":"1980","journal-title":"Clin Pharmacol Ther"},{"key":"10.1002\/jps.21698_bb0025","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1471-0528.1980.tb04501.x","article-title":"Twenty-four hours creatinine clearance during the third trimester of normal pregnancy","volume":"87","author":"Davison","year":"1980","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1002\/jps.21698_bb0030","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1128\/AAC.00420-06","article-title":"Pharmacokinetics and safety of indinavir in human immunodeficiency virus-infected pregnant women","volume":"51","author":"Unadkat","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1002\/jps.21698_bb0035","first-page":"310","article-title":"The disposition of caffeine during and after pregnancy","volume":"5","author":"Aldridge","year":"1981","journal-title":"Semin Perinatol"},{"key":"10.1002\/jps.21698_bb0040","doi-asserted-by":"crossref","first-page":"989","DOI":"10.2165\/00003088-200544100-00001","article-title":"Pregnancy-induced changes in pharmacokinetics: A mechanistic-based approach","volume":"44","author":"Anderson","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"10.1002\/jps.21698_bb0045","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s00228-003-0651-x","article-title":"Pregnancy and use of oral contraceptives reduces the biotransformation of proguanil to cycloguanil","volume":"59","author":"McGready","year":"2003","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1002\/jps.21698_bb0050","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1128\/AAC.48.2.430-436.2004","article-title":"Pharmacokinetics of saquinavir plus low-dose ritonavir in human immunodeficiency virus-infected pregnant women","volume":"48","author":"Acosta","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1002\/jps.21698_bb0055","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/clpt.2008.1","article-title":"Effects of pregnancy on CYP3A and P-glycoprotein activities as measured by disposition of Midazolam and Digoxin: A University of Washington Specialized Center of Research Study","volume":"84","author":"Hebert","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.1002\/jps.21698_bb0060","doi-asserted-by":"crossref","first-page":"G757","DOI":"10.1152\/ajpgi.00126.2002","article-title":"Expression of rat hepatic multidrug resistance-associated proteins and organic anion transporters in pregnancy","volume":"283","author":"Cao","year":"2002","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1002\/jps.21698_bb0065","doi-asserted-by":"crossref","first-page":"E1295","DOI":"10.1152\/ajpendo.00193.2006","article-title":"Expression of the breast cancer resistance protein (Bcrp1\/Abcg2) in tissues from pregnant mice: Effects of pregnancy and correlations with nuclear receptors","volume":"291","author":"Wang","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1002\/jps.21698_bb0070","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1053\/jhep.2001.20895","article-title":"Differential regulation of hepatic bile salt and organic anion transporters in pregnant and postpartum rats and the role of prolactin","volume":"33","author":"Cao","year":"2001","journal-title":"Hepatology"},{"key":"10.1002\/jps.21698_bb0075","doi-asserted-by":"crossref","first-page":"15665","DOI":"10.1073\/pnas.95.26.15665","article-title":"A multidrug resistance transporter from human MCF-7 breast cancer cells","volume":"95","author":"Doyle","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1002\/jps.21698_bb0080","doi-asserted-by":"crossref","first-page":"E118","DOI":"10.1208\/aapsj070112","article-title":"Role of the breast cancer resistance protein (ABCG2) in drug transport","volume":"7","author":"Mao","year":"2005","journal-title":"AAPS J"},{"key":"10.1002\/jps.21698_bb0085","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1146\/annurev.pharmtox.46.120604.141238","article-title":"Role of ABCG2\/BCRP in biology and medicine","volume":"46","author":"Krishnamurthy","year":"2006","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1002\/jps.21698_bb0090","first-page":"3458","article-title":"Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues","volume":"61","author":"Maliepaard","year":"2001","journal-title":"Cancer Res"},{"key":"10.1002\/jps.21698_bb0095","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1097\/00001756-200211150-00014","article-title":"Localisation of breast cancer resistance protein in microvessel endothelium of human brain","volume":"13","author":"Cooray","year":"2002","journal-title":"Neuroreport"},{"key":"10.1002\/jps.21698_bb0100","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1007\/s11095-008-9537-z","article-title":"BCRP\/ABCG2 in the placenta: Expression, function and regulation","volume":"25","author":"Mao","year":"2008","journal-title":"Pharm Res"},{"key":"10.1002\/jps.21698_bb0105","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1124\/dmd.107.018044","article-title":"Breast cancer resistance protein 1 limits fetal distribution of nitrofurantoin in the pregnant mouse","volume":"35","author":"Zhang","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1002\/jps.21698_bb0110","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1200\/JCO.2002.12.116","article-title":"Increased oral bioavailability of topotecan in combination with the breast cancer resistance protein and P-glycoprotein inhibitor GF120918","volume":"20","author":"Kruijtzer","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1002\/jps.21698_bb0115","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/sj.clpt.6100459","article-title":"Pharmacogenetic characterization of Sulfasalazine disposition based on NAT2 and ABCG2 (BCRP) gene polymorphisms in humans","volume":"84","author":"Yamasaki","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.1002\/jps.21698_bb0120","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cca.2006.05.010","article-title":"Role of BCRP 421C>A polymorphism on rosuvastatin pharmacokinetics in healthy Chinese males","volume":"373","author":"Zhang","year":"2006","journal-title":"Clin Chim Acta"},{"key":"10.1002\/jps.21698_bb0125","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1158\/0008-5472.CAN-03-2033","article-title":"Expression, up-regulation, and transport activity of the multidrug-resistance protein Abcg2 at the mouse blood\u2013brain barrier","volume":"64","author":"Cisternino","year":"2004","journal-title":"Cancer Res"},{"key":"10.1002\/jps.21698_bb0130","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1124\/mol.107.041616","article-title":"The Breast cancer resistance protein (Bcrp1\/Abcg2) limits fetal distribution of Glyburide in the pregnant mouse\u2014An Obstetric-Fetal Pharmacology Research Unit Network and University of Washington Specialized Center Of Research Study","volume":"73","author":"Zhou","year":"2008","journal-title":"Mol Pharmacol"},{"key":"10.1002\/jps.21698_bb0135","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1345\/aph.1D630","article-title":"Urinary tract infections during pregnancy","volume":"38","author":"Le","year":"2004","journal-title":"Ann Pharmacother"},{"key":"10.1002\/jps.21698_bb0140","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1124\/mol.104.010439","article-title":"The breast cancer resistance protein (BCRP\/ABCG2) affects pharmacokinetics, hepatobiliary excretion, and milk secretion of the antibiotic nitrofurantoin","volume":"67","author":"Merino","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1002\/jps.21698_bb0145","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1124\/dmd.106.011684","article-title":"Effects of the flavonoid chrysin on nitrofurantoin pharmacokinetics in rats: Potential involvement of ABCG2","volume":"35","author":"Wang","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1002\/jps.21698_bb0150","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1021\/js970114h","article-title":"Resampling methods in sparse sampling situations in preclinical pharmacokinetic studies","volume":"87","author":"Mager","year":"1998","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.21698_bb0155","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF00689272","article-title":"Flavone acetic acid and plasma protein binding","volume":"27","author":"Brodfuehrer","year":"1990","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1002\/jps.21698_bb0160","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/clpt.1981.115","article-title":"Nitrofurantoin disposition","volume":"29","author":"Hoener","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"10.1002\/jps.21698_bb0165","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/BF01062210","article-title":"Nonlinear assessment of nitrofurantoin bioavailability in rabbits","volume":"11","author":"Watari","year":"1983","journal-title":"J Pharmacokinet Biopharm"},{"key":"10.1002\/jps.21698_bb0170","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1124\/mol.105.011080","article-title":"Sex-dependent expression and activity of the ATP-binding cassette transporter breast cancer resistance protein (BCRP\/ABCG2) in liver","volume":"67","author":"Merino","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1002\/jps.21698_bb0175","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/BF00499260","article-title":"Reductive and oxidative metabolism of nitrofurantoin in rat liver","volume":"315","author":"Jonen","year":"1980","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1002\/jps.21698_bb0180","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000401065","article-title":"The pharmacokinetics of nitrofurantoin and its related bioavailability","volume":"25","author":"Conklin","year":"1978","journal-title":"Antibiot Chemother"},{"key":"10.1002\/jps.21698_bb0185","doi-asserted-by":"crossref","first-page":"15649","DOI":"10.1073\/pnas.202607599","article-title":"The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria","volume":"99","author":"Jonker","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1002\/jps.21698_bb0190","first-page":"178","article-title":"Biopharmaceutics of nitrofurantoin","volume":"8","author":"Conklin","year":"1972","journal-title":"Pharmacology"},{"key":"10.1002\/jps.21698_bb0195","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0022-3565(25)25940-7","article-title":"Studies on the absorption, distribution, and elimination of nitrofurantoin in the rat","volume":"131","author":"Buzard","year":"1961","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1002\/jps.21698_bb0200","doi-asserted-by":"crossref","first-page":"328","DOI":"10.2165\/00003088-199733050-00002","article-title":"Pharmacokinetic changes during pregnancy and their clinical relevance","volume":"33","author":"Loebstein","year":"1997","journal-title":"Clin Pharmacokinet"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915329245?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915329245?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T08:57:26Z","timestamp":1739091446000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354915329245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":39,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0022354915329245"],"URL":"https:\/\/doi.org\/10.1002\/jps.21698","relation":{},"ISSN":["0022-3549"],"issn-type":[{"type":"print","value":"0022-3549"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}